TG4040 in Patients With Chronic HCV

NCT00449124 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Placebo
BIOLOGICAL: TG4040

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)